PELVI-URETERIC OBSTRUCTION

This adverse event was reported 232 times

These drugs are most commonly taken by patients reporting PELVI-URETERIC OBSTRUCTION:

# Drug Count
0 FOLIC ACID 21
1 ADALIMUMAB 16
2 METHOTREXATE SODIUM 16
3 NAPROXEN SODIUM 15
4 ASPIRIN 14
5 ASPIRIN 325 MG 14
6 ASPIRIN 81 MG 14
7 METHOTREXATE 14
8 IBUPROFEN 13
9 PANTOPRAZOLE 13
See all common drugs associated with PELVI-URETERIC OBSTRUCTION

PELVI-URETERIC OBSTRUCTION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MITOMYCIN 7 0.0019
1 DROSPIRENONE AND ESTRADIOL 1 0.0019
2 GIVINOSTAT 1 0.0016
3 IXABEPILONE 1 0.0010
4 POTASSIUM ACETATE 1 0.0007
5 CLOMIPHENE CITRATE 1 0.0007
6 VAMOROLONE 1 0.0006
7 ALBENDAZOLE 1 0.0005
8 FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE 1 0.0004
9 NEOMYCIN OINTMENT 1 0.0004
See all drugs enriched for association with PELVI-URETERIC OBSTRUCTION